Glaxo's CEO Set to Highlight Cancer Ambitions With Key Drugs

Bookmark
(Bloomberg) -- GlaxoSmithKline Plc Chief Executive Officer Emma Walmsley is moving quickly to rebuild the U.K. pharma giant’s position in cancer, following an agreement last month to buy drugmaker ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.